Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
Xcellon Biologics, a Maryland CRDMO specializing in bioconjugates and complex biologics, has signed a definitive agreement to acquire the GMP biologics manufacturing facility built by NextCure, Inc. in Beltsville. The deal gives Xcellon its first cGMP capacity, completes the company’s transition from a development-stage CDMO into an end-to-end CRDMO, and puts a commissioned domestic bioconjugation […]
Read More →Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly. […]
Durham, North Carolina-based Ramona Optics, which develops imaging systems for biopharma and biomedical use, has closed an oversubscribed $25 million Series A financing round led by ARCH Venture Partners. Stealthpoint Ventures, ND Capital, Fall Line Capital, Hamamatsu Ventures, Dallas-based Murchison Capital Partners, and New York’s Overlap Holdings also participated. The round is Ramona’s first official […]
CorestemChemon, a biopharmaceutical company headquartered in South Korea, has begun U.S. operations based in Winston-Salem’s Innovation Quarter. Its U.S. subsidiary, CorestemChemon US Inc., currently has two executive-level employees in Winston-Salem, with plans to grow the team as its U.S. regulatory and clinical programs advance. The subsidiary is focused on U.S. commercialization of Neuronata-R, a stem […]
Pace Life Sciences, the life sciences division of science and technology company Pace, has named Andrew (Andy) Fenny as its President. “Pace Life Sciences has a strong foundation of scientific expertise, technical talent, and customer commitment,” said Fenny. “As life sciences organizations look for partners who can help deliver with speed and accuracy amidst evolving […]
The UNC Eshelman School of Pharmacy has received funding from the National Institutes of Health to launch the C³ Drug Delivery Predoctoral Training Program. It’s a new cross-institutional T32 program designed to prepare the next generation of scientists to translate drug delivery innovations into real-world therapies. The program brings together UNC-Chapel Hill, North Carolina State […]
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly. […]
CivaTech Oncology, an innovative radiation therapy company based in Morrisville, North Carolina, announced on October 1, 2026 the commercial launch of CivaDerm®, a radioactive bandage attached to the surface of the body to treat non-melanoma skin cancers. The treatment of the first five non-melanoma skin cancer patients marks an important milestone in expanding access to […]
Humacyte, Inc., a Durham, North Carolina-based commercial-stage biotechnology company developing universally implantable, bioengineered human tissues, announced on September 28, 2026, the appointment of Scott Coward and Paul Kuznik to its Board of Directors. The appointments come as Humacyte continues the commercial launch of Symvess and prepares for a planned launch of its acellular tissue engineered […]
Kincellis Advanced Therapies has appointed Bruce Thompson, Ph.D., as Chief Scientific Officer, where he will lead the company’s technical organization and CMC strategy as the newly merged cell therapy CDMO integrates its teams and capabilities. As Chief Scientific Officer, Thompson will focus on building scalable CMC strategies for Kincellis’ partners, spanning closed and automated processing, […]
